EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Protein-Coding RNA and Acute Kidney Injury: New Developments from Pathogenesis to Potential Biomarker

Grazia Maria Virzì iD, Anna Clementi, Monica Zanella, Claudio Ronco iD

Genes · 13.10.2025 · 16 (10) · 1194

DOI: 10.3390/genes16101194 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 13.10.2025. Verfasst von Grazia Maria Virzì und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, 36100 Vicenza, Italy. Hauptthemen laut MEDLINE: Acute Kidney Injury, MicroRNAs, RNA, Untranslated. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute Kidney Injury (AKI) is a critical medical condition characterized by a sudden and significant decline in renal function over a short timeframe. Commonly triggered by factors such as sepsis, ischemia–reperfusion injury, or nephrotoxic agents, AKI is linked to substantial rates of morbidity and mortality. In recent years, small non-coding RNAs have gained attention as promising biomarkers for the early diagnosis and potential treatment of AKI. Among them, microRNAs (miRNAs)—short RNA sequences of 21–25 nucleotides that regulate gene expression via sequence-specific binding—stand out due to their remarkable stability in biological fluids such as plasma and urine. Notably, certain miRNAs, including miR-21, miR-30, miR-494, and miR-29, have shown the ability to detect AKI earlier than traditional biomarkers like serum creatinine, offering the potential to enhance clinical decision-making. This narrative review aims to provide a comprehensive overview of the recent findings regarding the involvement of non-coding RNA, in particular microRNAs, in both the early diagnosis and therapeutic strategies for AKI. By highlighting their potential as sensitive biomarkers and novel treatment targets, this review seeks to contribute to advancing clinical approaches that improve patient outcomes. Ultimately, a deeper understanding and utilization of microRNAs could lead to the development of new diagnostic tools and targeted therapies for AKI, helping to prevent progression to chronic kidney disease and reduce associated mortality rates. However, further clinical studies and translational applications are still needed to validate these findings and implement them in patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryMicroRNAsRNA, UntranslatedHumansBiomarkersAnimals

Stichwörter der Autor:innen

AKImicroRNAmicrovesciclesnon-protein-coding RNA

Substanzen

BiomarkersMicroRNAsRNA, Untranslated

Autor:innen und Institutionen

  • Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, 36100 Vicenza, Italy.
  • IRRIV-International Renal Research Institute Vicenza-Foundation, 36100 Vicenza, Italy.
  • Department of Nephrology and Dialysis, Santa Marta and Santa Venera Hospital, 95024 Acireale, Italy.

ORCID-Profile: Grazia Maria Virzì, Claudio Ronco

Zitieren

APA

Virzì, G. M., Clementi, A., Zanella, M., & Ronco, C. (2025). Non-Protein-Coding RNA and Acute Kidney Injury: New Developments from Pathogenesis to Potential Biomarker. Genes, 16(10), 1194. https://doi.org/10.3390/genes16101194

Vancouver

Virzì GM, Clementi A, Zanella M, Ronco C. Non-Protein-Coding RNA and Acute Kidney Injury: New Developments from Pathogenesis to Potential Biomarker. Genes. 2025;16(10):1194. doi:10.3390/genes16101194

BibTeX
@article{Virz2025,
  author = {Virzì, Grazia Maria and Clementi, Anna and Zanella, Monica and Ronco, Claudio},
  title = {Non-Protein-Coding RNA and Acute Kidney Injury: New Developments from Pathogenesis to Potential Biomarker},
  journal = {Genes},
  year = {2025},
  volume = {16},
  number = {10},
  pages = {1194},
  doi = {10.3390/genes16101194}
}
Kostenlos starten →